Pfizer Pushes Champix In India Through Private Hospitals And Clinics As Smoking Epidemic Hits India
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - A smoking epidemic that kills nearly a million people in India every year has led Pfizer to get aggressive on collaborating with private sector healthcare units to open 600 smoking cessation clinics in the next two years
You may also be interested in...
Pfizer’s Champix Faces Patent Hurdle In India As Dr Reddy’s Raise Questions
Dr. Reddy’s has been very selective in challenging Indian patents of multinational companies, so lawyers speculate that the undisclosed grounds for the challenge must be very strong.
Pfizer’s Champix Faces Patent Hurdle In India As Dr Reddy’s Raise Questions
Dr. Reddy’s has been very selective in challenging Indian patents of multinational companies, so lawyers speculate that the undisclosed grounds for the challenge must be very strong.
Pfizer Follows Novartis; Offers To Up Stake In Indian Arm To 75 Percent
Pharma plans further launches of its patented products in emerging market.